B

BioSenic
BIOS

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€848.72K
EV
€26.89M
Shares Outstanding
652.86M
Beta
-2.74

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E 2024E
-
P/Revenue 2024E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About BioSenic S.A.

gainify

B

BioSenic S.A.

BIOS

BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the h...

Sector

Healthcare

Industry

Biotechnology

CEO

Data Unavailable

Employees

IPO Date

2015-02-03

Headquarters

Building H (box 24), Rue GranbonprE 11, Mont-Saint-Guibert, Walloon Brabant, 1435, Belgium

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved